Novatech SA   Report issue

For profit Phase 3
Founded: La Ciotat France (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
None
First Marketed Drug
2017
talc (sclerosol)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

NOVATECH SA

Active Ingredients

Marketed Drugs (1)

talc (sclerosol) (2017)

Drugs in Phase 3 Trials (2)

Key: Novatech SA (0) Acquired (2)

riboflavin (1 trial)

sodium chloride (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 2